David Silberman
Vermögen: 93 365 $ am 31.05.2026
Vermögen: 93 365 $ am 31.05.2026
David Silberman currently works at Nasus Pharma Ltd., as Director from 2025 and Compugen Ltd., as Chief Financial Officer from 2024.
Mr. Silberman also formerly worked at Teva Pharmaceutical Industries Ltd., as Senior Manager-Global Internal Audit from 2018 to 2021 and Oramed Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Treasurer from 2021 to 2022.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
COMPUGEN LTD. 0.04% | 18.03.2026 | 35’500 ( 0.04% ) | 93 365 $ | 31.05.2026 |
NASUS PHARMA LTD. -.--% | 25.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| COMPUGEN LTD. | Finanzdirektor/CFO | 15.08.2024 |
| NASUS PHARMA LTD. | Direktor/Vorstandsmitglied | 11.08.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Finanzdirektor/CFO | 09.01.2022 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Comptroller/Controller/Auditor | 01.05.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Compugen Ltd.
Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Oramed Pharmaceuticals, Inc.
Oramed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Nasus Pharma Ltd.
Nasus Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops powder-based intranasal products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen